GRAIL, Inc. (California, U.S.), the company developing and funding the research, has now made the multi-cancer early detection test available in the U.S. by prescription only, and to complement other, existing screening methods such as those for breast, ...
from Google Alert - health https://ift.tt/3dvQZLV
via IFTTT
0 comments:
Post a Comment